Legal Opinion
Boles v. Merck & Co.
District Court, S.D. New York
Decided October 4, 2010No. Case No. 1:06-cv-09455-JFK; No. 06-MD-1789-JFKPublishedCited by 1 opinion
1Opinion of the Court
OPINION & ORDER
JOHN F. KEENAN, District Judge:
This case was selected by the Plaintiffs’ Steering Commit tee as a bellwether case in this multidistrict products liability litigation concerning Defendant Merck Sharpe & Dohme Corp.’s (“Merck” or “Defendant”) prescription drug Fosamax. The case went to trial in August 2009 and ended in a mistrial after the jury could not reach a unanimous verdict. The contentious re-trial in June 2010 culminated with an $8 million verdict for Plaintiff Shirley Boles (“Plaintiff’ or “Boles”). Before the Court are Merck’s motions for judgment as a matter of law and…
2Cases cited58 opinions
- Medtronic, Inc. v. LohrSupreme Court of the United States · 1996
- Gasperini v. Center for Humanities, Inc.Supreme Court of the United States · 1996
- Wyeth v. LevineSupreme Court of the United States · 2009
- Browning-Ferris Industries of Vermont, Inc. v. Kelco Disposal, Inc.Supreme Court of the United States · 1989
- Riegel v. Medtronic, Inc.Supreme Court of the United States · 2008
53 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- In Re Fosamax Products Liability LitigationDistrict Court, S.D. New York · 2010